CorMedix (CRMD) Return on Equity [ROE] (2011 - 2026)
CorMedix's Return on Equity [ROE] came in at 25.54% for Q2 2026, up 5.65 percentage points from 19.88% a year earlier.
Powered by 
Analysis
CorMedix (CRMD) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, CorMedix's Return on Equity [ROE] was 0.69%, up 23.86 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +65.61 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -23.17% in FY2024 (+50.86 pp), -74.02% in FY2023 (-23.62 pp), -50.40% in FY2022 (+2.32 pp) and -52.72% in FY2021 (+12.19 pp).
- The five-year range for quarterly Return on Equity [ROE] is -101.94% (Q2 2024) to 48.66% (Q3 2025).
- Year-over-year, Return on Equity [ROE] increased in six of the last seven quarters, with an average year-over-year change of +60.86 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2025 (a gain of 136.65 percentage points), and the weakest in Q2 2024 (a drop of 30.27 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | CorMedix | 598.04 Mn | -54.48 Mn | 77.13 Mn | 25.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.54% |
| Dec 31, 2025 | 33.67% |
| Sep 30, 2025 | 48.66% |
| Jun 30, 2025 | 19.88% |
| Mar 31, 2025 | 17.22% |
| Dec 31, 2024 | -25.01% |
| Sep 30, 2024 | -87.99% |
| Jun 30, 2024 | -101.94% |
| Mar 31, 2024 | -78.40% |
| Dec 31, 2023 | -60.44% |
| Sep 30, 2023 | -60.18% |
| Jun 30, 2023 | -71.67% |
| Mar 31, 2023 | -60.99% |
| Dec 31, 2022 | -53.32% |
| Sep 30, 2022 | -49.59% |
| Jun 30, 2022 | -50.97% |
| Mar 31, 2022 | -45.68% |
| Dec 31, 2021 | -42.69% |
| Sep 30, 2021 | -36.25% |
| Jun 30, 2021 | -31.22% |
API Access
CorMedix Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();